Clinical trial
Ambien CR For Treatment Of Insomnia Associated With Depression When Used…
NCT00296179 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00296179 |
|---|---|
| Title | Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With Lexapro |
| Official title | Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder(MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | zolpidem tartrate |
| Enrollment | 372 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2007 |
| First posted | Feb 24, 2006 |
| Last update posted | Jul 28, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: